Opinion: China isn’t yet ready to conduct clinical trials for the pharma industry
by Anne Poli
Aug 03, 2018
3 minutes
China, with its huge population and its position as the second-largest pharmaceutical market in the world, should be poised to become a world leader in clinical trials for new drugs and devices. But it isn’t quite ready for that.
Problems with protecting clinical trial participants, inadequate clinical trial infrastructure, and poor transparency make China an unreliable country in which to conduct a clinical trial. As a clinical research professional with more than a decade of global industry experience, I’ve seen
You’re reading a preview, subscribe to read more.
Start your free 30 days